143 related articles for article (PubMed ID: 15647215)
1. Implantable cardioverter defibrillators: an excellent case study.
Stanton MS
Health Aff (Millwood); 2005; 24(1):52-4. PubMed ID: 15647215
[TBL] [Abstract][Full Text] [Related]
2. Evidence-based medicine and policy: the case of the implantable cardioverter defibrillator.
Hlatky MA; Sanders GD; Owens DK
Health Aff (Millwood); 2005; 24(1):42-51. PubMed ID: 15647214
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of a microvolt T-wave alternans screening strategy for implantable cardioverter-defibrillator placement in the MADIT-II-eligible population.
Chan PS; Stein K; Chow T; Fendrick M; Bigger JT; Vijan S
J Am Coll Cardiol; 2006 Jul; 48(1):112-21. PubMed ID: 16814657
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
[TBL] [Abstract][Full Text] [Related]
5. The Economics of ICDs.
Jauhar S; Slotwiner DJ
N Engl J Med; 2004 Dec; 351(24):2542-4. PubMed ID: 15590958
[No Abstract] [Full Text] [Related]
6. Preventing sudden death: implantable cardioverter-defibrillators in elderly cardiac patients.
Groeneveld PW
LDI Issue Brief; 2008; 13(6):1-4. PubMed ID: 18613344
[TBL] [Abstract][Full Text] [Related]
7. The high cost of implantable defibrillators.
Hlatky MA; Mark DB
Eur Heart J; 2007 Feb; 28(4):388-91. PubMed ID: 17032689
[TBL] [Abstract][Full Text] [Related]
8. Benefits of the implantable cardioverter-defibrillator.
Epstein AE
J Am Coll Cardiol; 2008 Sep; 52(14):1122-7. PubMed ID: 18804737
[TBL] [Abstract][Full Text] [Related]
9. Role of implantable cardioverter defibrillators in non-ischaemic dilated cardiomyopathy.
Scott PA; Roberts PR
Postgrad Med J; 2010 Feb; 86(1012):116-22. PubMed ID: 20145061
[TBL] [Abstract][Full Text] [Related]
10. Microvolt T-wave alternans and the selective use of implantable cardioverter defibrillators for primary prevention: a cost-effectiveness study.
Filion KB; Xie X; van der Avoort CJ; Dendukuri N; Brophy JM
Int J Technol Assess Health Care; 2009 Apr; 25(2):151-60. PubMed ID: 19331707
[TBL] [Abstract][Full Text] [Related]
11. A critical appraisal of implantable cardioverter-defibrillator therapy for the prevention of sudden cardiac death.
Tung R; Zimetbaum P; Josephson ME
J Am Coll Cardiol; 2008 Sep; 52(14):1111-21. PubMed ID: 18804736
[TBL] [Abstract][Full Text] [Related]
12. Cost-effectiveness in a flat world--can ICDs help the United States get rhythm?
Goldman L
N Engl J Med; 2005 Oct; 353(14):1513-5. PubMed ID: 16207856
[No Abstract] [Full Text] [Related]
13. Medicare coverage of ICDs.
McClellan MB; Tunis SR
N Engl J Med; 2005 Jan; 352(3):222-4. PubMed ID: 15659721
[No Abstract] [Full Text] [Related]
14. Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
Mark DB; Nelson CL; Anstrom KJ; Al-Khatib SM; Tsiatis AA; Cowper PA; Clapp-Channing NE; Davidson-Ray L; Poole JE; Johnson G; Anderson J; Lee KL; Bardy GH;
Circulation; 2006 Jul; 114(2):135-42. PubMed ID: 16818817
[TBL] [Abstract][Full Text] [Related]
15. Implantable cardioverter-defibrillators.
Mack MJ
N Engl J Med; 2005 May; 352(19):2022-5; author reply 2022-5. PubMed ID: 15888706
[No Abstract] [Full Text] [Related]
16. Grasping the role of technology: a conversation with Ron Dollens. Interview by John K. Iglehart.
Dollens R
Health Aff (Millwood); 2005; Suppl Web Exclusives():W5-296-W5-313. PubMed ID: 15975988
[TBL] [Abstract][Full Text] [Related]
17. The long-term cost-effectiveness of cardiac resynchronization therapy with or without an implantable cardioverter-defibrillator.
Yao G; Freemantle N; Calvert MJ; Bryan S; Daubert JC; Cleland JG
Eur Heart J; 2007 Jan; 28(1):42-51. PubMed ID: 17110403
[TBL] [Abstract][Full Text] [Related]
18. Impact of implantable-cardioverter-defibrillator trials on clinical management of patients with heart failure.
Winslow RD; Pinney S; Fuster V
Nat Clin Pract Cardiovasc Med; 2006 Feb; 3(2):86-93. PubMed ID: 16446777
[TBL] [Abstract][Full Text] [Related]
19. [Usefulness of the implantable cardiodefibrillator (ICD) in the prevention of sudden death. Results of evidence based medicine].
González CM
Arch Cardiol Mex; 2007; 77 Suppl 2():S2-44-S2-46. PubMed ID: 17972377
[TBL] [Abstract][Full Text] [Related]
20. Life expectancy gains and cost-effectiveness of implantable cardioverter/defibrillators for the primary prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy.
You JJ; Woo A; Ko DT; Cameron DA; Mihailovic A; Krahn M
Am Heart J; 2007 Nov; 154(5):899-907. PubMed ID: 17967596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
